About Vejon Consultive

At Vejon Consultive, our mission is to empower individuals to take control of their health by addressing the root causes of chronic conditions and subclinical inflammation. While we initially focused on supporting long haulers, we have expanded our services, incorporating a more comprehensive approach to overall wellness.
Led by Dr Philip McMillan, a pioneer in Covid-19 research and immune health, we are committed to helping you navigate the complexities of chronic illness and inflammation. Whether you’re struggling with long-term Covid symptoms or autoimmune disorders, or simply seeking to optimize your health, we offer tailored solutions designed to meet your unique needs.
Why We’re Different
At Vejon Consultive, we take a personalized approach to health and wellness. Dr McMillan has been at the forefront of research on Covid-19 and autoimmune responses, with a deep understanding of how subclinical inflammation drives many of today’s common health issues. Through our consultations, we work directly with you to identify the underlying drivers, including hidden factors, and to create actionable strategies to maintain and improve your health and wellness.
Our Commitment to You
We believe that true health comes from understanding the body’s complex systems and addressing the root causes of illness. If you're navigating the after-effects of long Covid, dealing with chronic health concerns or simply trying to maintain or improve your overall health and wellness, we are here to support you on your journey.
Join us and discover a path to health that works from the inside out.
About Dr Philip McMillan, MB BS, MRCP(UK)
Dr Philip McMillan is a physician, researcher and international keynote speaker with an innovative approach to the development of solutions for autoimmune disorders, subclinical inflammation, long haul disease and long-term Covid symptoms.
He was the first to outline a theory of autoimmunity in Covid-19, and he shares valuable research on science and health through published papers and social media. He hosts a series of panels and conferences which bring together international experts on Covid-19 and long Covid. He also interviews a broad range of global experts, reaching over 15 million views on social media.
Dr McMillan’s work on long haul disease is a natural evolution of his research on autoimmunity in Covid-19. Through collaboration with specialists such as Dr Bruce Patterson, he has advanced the understanding and treatment of long haulers.
He focuses on identifying the primary drivers for subclinical inflammation and incorporates this into his clinical practice. Dr McMillan applies new thinking to the development of solutions for his patients and, in the process, hopes to uncover critical links to chronic fatigue syndrome (CFS).
Dr McMillan applies his research technique to improving the understanding of complex disease. He has observed that the primary pathology of a disease is typically several steps away from the visible symptoms. In the case of Covid-19, he proposed that severe disease is a viral-mediated autoimmune response. In April 2020, Dr McMillan first outlined the theory of autoimmunity in Covid-19 which was based on the interaction between the viral spike protein and serum ACE-2, and was subsequently published in a paper co-authored by Prof Bruce Uhal, the top pulmonary ACE-2 researcher globally. Research at Johns Hopkins University has since (October 2020) confirmed autoantibodies to ACE-2 in the serum of severely affected patients, supporting the theory of autoimmunity in Covid-19.
Dr McMillan is the founder of the Vejon Health Group of Companies which focuses on research into complex medical conditions, with the goal of finding solutions for inflammatory conditions, Covid-19, long haul disease, dementia, osteoporosis and type 2 diabetes.
Published Papers

Dr McMillan and his co-authors were the first to published a paper on Covid-19 autoimmunity involving plasma/serum ACE-2.
This paper, published in Frontiers has over 22,000 views and over 50 citations around autoimmunity in COVID-19!

McMillan, Philip, Anthony J. Turner, and Bruce D. Uhal. "Mechanisms of Gut-Related Viral Persistence in Long COVID." Viruses 16.8 (2024): 1266.
Authorship
